Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Hypoxia As an Enhancer of Inflammation-Mediated Metastasis: Emerging Therapeutic Strategies
Authors
Keywords
-
Journal
Targeted Oncology
Volume 13, Issue 2, Pages 157-173
Publisher
Springer Nature
Online
2018-02-08
DOI
10.1007/s11523-018-0555-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- Hypoxia Selectively Enhances Integrin α 5 β 1 Receptor Expression in Breast Cancer to Promote Metastasis
- (2017) Julia A. Ju et al. MOLECULAR CANCER RESEARCH
- The unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors
- (2017) Heather Nesbitt et al. PROSTATE
- Inflammation fires up cancer metastasis
- (2017) Bin-Zhi Qian SEMINARS IN CANCER BIOLOGY
- Synergistic IL-6 and IL-8 paracrine signalling pathway infers a strategy to inhibit tumour cell migration
- (2017) Hasini Jayatilaka et al. Nature Communications
- Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
- (2017) Vasilios Liapis et al. Cancer Medicine
- Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis
- (2017) Kota Wakiyama et al. Scientific Reports
- Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
- (2016) Francis W Hunter et al. BRITISH JOURNAL OF CANCER
- PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis
- (2016) D. Samanta et al. CANCER RESEARCH
- Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote Metastasis
- (2016) L.-Y. Ye et al. CANCER RESEARCH
- Neutrophil Extracellular Traps Promote the Development and Progression of Liver Metastases after Surgical Stress
- (2016) Samer Tohme et al. CANCER RESEARCH
- A Small-Molecule Antagonist of HIF2α Is Efficacious in Preclinical Models of Renal Cell Carcinoma
- (2016) Eli M. Wallace et al. CANCER RESEARCH
- Hypoxia-inducible factor-targeting prodrug TOP3 combined with gemcitabine or TS-1 improves pancreatic cancer survival in an orthotopic model
- (2016) Ngoc Thi Hong Hoang et al. CANCER SCIENCE
- Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression
- (2016) Heather Nesbitt et al. CLINICAL CANCER RESEARCH
- Combination of preoperative platelet/lymphocyte and neutrophil/lymphocyte rates and tumor-related factors to predict lymph node metastasis in patients with gastric cancer
- (2016) Wenyang Pang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Hypoxia-inducible factor (HIF) inhibitors: a patent survey (2011-2015)
- (2016) Hyun Seung Ban et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
- (2016) David Kung-Chun Chiu et al. HEPATOLOGY
- Down-regulation of TIMP2 by HIF-1α/miR-210/HIF-3α regulatory feedback circuit enhances cancer metastasis in hepatocellular carcinoma
- (2016) Alan Ka-Lun Kai et al. HEPATOLOGY
- Implications of Hypoxia in Breast Cancer Metastasis to Bone
- (2016) Daniele Gilkes INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Response of Macrophages and Neutrophils to Hypoxia in the Context of Cancer and Other Inflammatory Diseases
- (2016) Antje Egners et al. MEDIATORS OF INFLAMMATION
- Targeting renal cell carcinoma with a HIF-2 antagonist
- (2016) Wenfang Chen et al. NATURE
- Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
- (2016) S Chouaib et al. ONCOGENE
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis
- (2016) Bajin Wei et al. OncoTargets and Therapy
- Infliximab enhances the therapeutic effects of 5-fluorouracil resulting in tumor regression in colon cancer
- (2016) Fen Liu et al. OncoTargets and Therapy
- HIF-1α-PDK1 axis-induced active glycolysis plays an essential role in macrophage migratory capacity
- (2016) Hiroaki Semba et al. Nature Communications
- Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
- (2016) Ines Lohse et al. Oncotarget
- Stromal-Initiated Changes in the Bone Promote Metastatic Niche Development
- (2016) Xianmin Luo et al. Cell Reports
- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- Carbonic Anhydrase IX Promotes Myeloid-Derived Suppressor Cell Mobilization and Establishment of a Metastatic Niche by Stimulating G-CSF Production
- (2015) S. C. Chafe et al. CANCER RESEARCH
- FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
- (2015) A. Deisseroth et al. CLINICAL CANCER RESEARCH
- Novel chalcone derivatives as hypoxia-inducible factor (HIF)-1 inhibitor: Synthesis, anti-invasive and anti-angiogenic properties
- (2015) Lihui Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- NF-κB and HIF crosstalk in immune responses
- (2015) Laura D'Ignazio et al. FEBS Journal
- Hypoxia Potentiates Palmitate-induced Pro-inflammatory Activation of Primary Human Macrophages
- (2015) Ryan G. Snodgrass et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia Promotes the Inflammatory Response and Stemness Features in Visceral Fat Stem Cells From Obese Subjects
- (2015) Elisa Petrangeli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
- (2015) Douglas Marvel et al. JOURNAL OF CLINICAL INVESTIGATION
- Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs
- (2015) Jen Jen Yeh et al. JOURNAL OF CLINICAL ONCOLOGY
- CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
- (2015) Takanori Kitamura et al. JOURNAL OF EXPERIMENTAL MEDICINE
- New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis
- (2015) Honor J. Hugo et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Neutrophils support lung colonization of metastasis-initiating breast cancer cells
- (2015) Stefanie K. Wculek et al. NATURE
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth
- (2015) Wenchao Zhou et al. NATURE CELL BIOLOGY
- Inflammation and cancer: advances and new agents
- (2015) Shanthini M. Crusz et al. Nature Reviews Clinical Oncology
- Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1
- (2015) Tina El Rayes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HSP90 Inhibition Suppresses Lipopolysaccharide-Induced Lung Inflammation In Vivo
- (2015) Andrew Lilja et al. PLoS One
- Macrophages are recruited to hypoxic tumor areas and acquire a Pro-Angiogenic M2-Polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin
- (2015) Chakrapani Tripathi et al. Oncotarget
- Intermittent Hypoxia-induced Changes in Tumor-associated Macrophages and Tumor Malignancy in a Mouse Model of Sleep Apnea
- (2014) Isaac Almendros et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
- (2014) Shicheng Su et al. CANCER CELL
- Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Qing-Min Fan et al. CANCER LETTERS
- Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone
- (2014) Yu Zheng et al. CLINICAL & EXPERIMENTAL METASTASIS
- Transmigrating Neutrophils Shape the Mucosal Microenvironment through Localized Oxygen Depletion to Influence Resolution of Inflammation
- (2014) Eric L. Campbell et al. IMMUNITY
- Direct Crosstalk Between Cancer and Osteoblast Lineage Cells Fuels Metastatic Growth in Bone via Auto-Amplification of IL-6 and RANKL Signaling Pathways
- (2014) Yu Zheng et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma
- (2014) Sant P. Chawla et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation
- (2014) Muhammad Zaeem Noman et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CCL2 Shapes Macrophage Polarization by GM-CSF and M-CSF: Identification of CCL2/CCR2-Dependent Gene Expression Profile
- (2014) E. Sierra-Filardi et al. JOURNAL OF IMMUNOLOGY
- Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma
- (2014) Tobias Bald et al. NATURE
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis and are targets of metastasis-inducing S100A4
- (2014) M T Hansen et al. ONCOGENE
- Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts
- (2014) M. Ammirante et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
- (2014) P. Chaturvedi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia
- (2014) Lei-Lei Tao WORLD JOURNAL OF GASTROENTEROLOGY
- Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
- (2014) Theerawut Chanmee et al. Cancers
- Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
- (2014) Martin Augsten Frontiers in Oncology
- Hypoxia Promotes Danger-mediated Inflammation via Receptor for Advanced Glycation End Products in Cystic Fibrosis
- (2013) Rossana G. Iannitti et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Targeting connective tissue growth factor (CTGF) in acute lymphoblastic leukemia preclinical models: anti-CTGF monoclonal antibody attenuates leukemia growth
- (2013) Hongbo Lu et al. ANNALS OF HEMATOLOGY
- Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction
- (2013) T Nagasaki et al. BRITISH JOURNAL OF CANCER
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
- (2013) Peter M. Voorhees et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impeding Macrophage Entry into Hypoxic Tumor Areas by Sema3A/Nrp1 Signaling Blockade Inhibits Angiogenesis and Restores Antitumor Immunity
- (2013) Andrea Casazza et al. CANCER CELL
- Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
- (2013) Woondong Jeong et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Tumor Hypoxia Does Not Drive Differentiation of Tumor-Associated Macrophages but Rather Fine-Tunes the M2-like Macrophage Population
- (2013) D. Laoui et al. CANCER RESEARCH
- Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
- (2013) Shun-Pei Hung et al. CELL TRANSPLANTATION
- Role of hypoxia-inducible factors in breast cancer metastasis
- (2013) Daniele M Gilkes et al. Future Oncology
- Activity of the hypoxia-activated pro-drug TH-302 in hypoxic and perivascular regions of solid tumors and its potential to enhance therapeutic effects of chemotherapy
- (2013) Jasdeep K. Saggar et al. INTERNATIONAL JOURNAL OF CANCER
- Hypoxia-inducible Factor 1 (HIF-1) Promotes Extracellular Matrix Remodeling under Hypoxic Conditions by InducingP4HA1, P4HA2,andPLOD2Expression in Fibroblasts
- (2013) Daniele M. Gilkes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
- (2013) Murielle Mimeault et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
- (2013) Pallavi Chaturvedi et al. JOURNAL OF CLINICAL INVESTIGATION
- TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer
- (2013) Neil E. Bhola et al. JOURNAL OF CLINICAL INVESTIGATION
- Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer
- (2013) Lisha Xiang et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial
- (2013) Jesus San Miguel et al. LANCET ONCOLOGY
- Tumor Necrosis Factor Alpha-Induced Hypoxia-Inducible Factor 1 - -Catenin Axis Regulates Major Histocompatibility Complex Class I Gene Activation through Chromatin Remodeling
- (2013) S. Ghosh et al. MOLECULAR AND CELLULAR BIOLOGY
- Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
- (2013) G Comito et al. ONCOGENE
- CTGF is a therapeutic target for metastatic melanoma
- (2013) E C Finger et al. ONCOGENE
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
- (2013) A. Neesse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
- (2013) Christopher P. Guise et al. Chinese Journal of Cancer
- Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features
- (2012) A. K. Azab et al. BLOOD
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- New Paradigm for Intrinsic Function of Heat Shock Proteins as Endogenous Ligands in Inflammation and Innate Immunity
- (2012) Y. Tamura et al. CURRENT MOLECULAR MEDICINE
- The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development
- (2012) CANDACE E. CARROLL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Recent agents targeting HIF-1α for cancer therapy
- (2012) Yaozhong Hu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hypoxia enhances the interaction between pancreatic stellate cells and cancer cells via increased secretion of connective tissue growth factor
- (2012) Daiki Eguchi et al. JOURNAL OF SURGICAL RESEARCH
- Selective Inhibition of Hypoxia-Inducible Factor 1 Ameliorates Adipose Tissue Dysfunction
- (2012) K. Sun et al. MOLECULAR AND CELLULAR BIOLOGY
- Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts
- (2012) L J A C Hawinkels et al. ONCOGENE
- Cancer Associated Fibroblasts Exploit Reactive Oxygen Species Through a Proinflammatory Signature Leading to Epithelial Mesenchymal Transition and Stemness
- (2011) Elisa Giannoni et al. ANTIOXIDANTS & REDOX SIGNALING
- A novel approach to cancer therapy using PX-478 as a HIF-1α inhibitor
- (2011) Kyeong Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth
- (2011) Xinhai Wan et al. BONE
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
- (2011) Rachel F. Gabitass et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
- (2011) N. Obermajer et al. CANCER RESEARCH
- Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
- (2011) Eric V. Dang et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
- (2011) Nadine Rohwer et al. DRUG RESISTANCE UPDATES
- Dynamic regulation of Th17 differentiation by oxygen concentrations
- (2011) A. Ikejiri et al. INTERNATIONAL IMMUNOLOGY
- HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Tregcells
- (2011) Lewis Z. Shi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
- (2011) Bin-Zhi Qian et al. NATURE
- HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs
- (2011) H Zhang et al. ONCOGENE
- A Phase I Study of the Safety and Pharmacokinetics of the Hypoxia-Activated Prodrug TH-302 in Combination with Doxorubicin in Patients with Advanced Soft Tissue Sarcoma
- (2011) Kristen N. Ganjoo et al. ONCOLOGY
- Macrophage Expression of Hypoxia-Inducible Factor-1 Suppresses T-Cell Function and Promotes Tumor Progression
- (2010) A. L. Doedens et al. CANCER RESEARCH
- Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
- (2010) X. Lu et al. CLINICAL CANCER RESEARCH
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HIF-1 and HIF-2 transcription factors — Similar but not identical
- (2010) Agnieszka Loboda et al. MOLECULES AND CELLS
- Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
- (2009) Chie Kudo-Saito et al. CANCER CELL
- Vorinostat Inhibits Brain Metastatic Colonization in a Model of Triple-Negative Breast Cancer and Induces DNA Double-Strand Breaks
- (2009) D. Palmieri et al. CLINICAL CANCER RESEARCH
- Regulation of Oxygen Homeostasis by Hypoxia-Inducible Factor 1
- (2009) Gregg L. Semenza PHYSIOLOGY
- Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis
- (2008) John W. Rice et al. ARTHRITIS AND RHEUMATISM
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity
- (2008) R. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- A RNA antagonist of hypoxia-inducible factor-1 , EZN-2968, inhibits tumor cell growth
- (2008) L. M. Greenberger et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2008) John Klune et al. MOLECULAR MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now